medicine news

Geneva - Asian countries, youngsters and people spoiled by the availability of medicines in the developed world are high-risk communities for HIV infection in the upcoming year, expert...

Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, the European Commission says.

Identification of 2-[2-nitro-4-(trifluoromethyl)benzoyl]-cyclohexane-1,3-dione metabolites in urine of patients suffering from tyrosinemia type I with the use of (1)H and (19)F NMR spectroscopy. Acta Biochim Pol. 2008 Nov 28; Authors: Szczeciński P, Lamparska D, Gryff-Keller A, Gradowska W Organic extracts of six urine samples from children treated with nitisinone, a medicine against tyrosinemia type I, were investigated by (1)H and (19)F NMR spectroscopy. The presence of unchanged 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione (NTBC), 6-hydroxy-2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione (NTBC-OH) and 2-nitro-4-trifluoromethylbenzoic acid (NTFA) as well as a few other unidentified compounds containing CF(3) group was documented. PMID: 190...

Media coverage of clinical trials does not contain the elements readers require to make informed decisions. A comparison of the coverage received by pharmaceutical and herbal remedy trials, reported in the open access journal BMC Medicine, has revealed that it is rarely possible for the lay public to assess the credibility of the described research.

If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill school of Medicine takes a step in that direction. Carol Otey, Ph.D. and UNC colleagues reduced the ability of breast cancer cells to migrate by knocking down the expression of a protein called palladin. They also found higher levels of palladin in four invasive breast cancer cell lines compared to four non-invasive cell lines. 'This study shows that palladin may play an important role in the metastasis of breast cancer cells as they move out of the tumor and into the blood vessels and lymphatics to spread throughout the body,' s...

A new study provides limited evidence that physicians could make fewer mistakes on the job by abandoning paper-based medicine in favor of electronic health records.The findings are not definitive. Still, they 'suggest that electronic health records may prevent medical errors and malpractice claims,' said study co-author Steven Simon, M.D., an internist and health researcher at Harvard Medical school.read more